May 07, 2022
In this special edition ATTD Recap episode of Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini provide insight from ATTD 2022, including the latest updates in the world of diabetes smartphone apps, smart insulin pens, and CGM systems.
April 28, 2022
In the April 2022 edition of Diabetes Dialogue: Therapeutics, Technology, and Real-World Perspectives, hosts Drs. Diana Isaacs and Natalie Bellini discuss the implications of the FDA's approval of semaglutide 2.0 mg, the use of novel glycemic control metrics, and a preview of ATTD 2022.
March 30, 2022
The inaugural episode of Diabetes Dialogue features an introduction to hosts Diana Isaacs, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, and Natalie Bellini, DNP, FNP-BC, and a discussion around recent regulatory news surrounding CGM devices in the US and Europe.
March 16, 2021
Check out the Endocrine Outlook podcast, brought to you by the Endocrinology Network. This episode focuses on semaglutide 1 mg as a weight loss therapy for patients who are obese or overweight.
February 17, 2021
This episode of the Endocrine Outlook podcast features an interview on dietary interventions and the role of nutrition in obesity management with Ariana Chao, PhD, CRNP, of the University of Pennsylvania.
December 07, 2020
Dr. Jeffrey Curtis discusses osteoporosis data presented at ACR Convergence and the current state of osteoporosis management in 2020 in the latest edition of the Endocrine Outlook podcast.
November 02, 2020
Georgiana Dobri, MD, a neuroendocrinologist from Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.
October 30, 2020
A podcast episode featuring a discussion related to racial and ethnic disparities in the care of children with type 1 diabetes.
October 19, 2020
Raymond Douglas, MD, PhD, discusses trends in treatment of thyroid eye disease and how the approval of teprotumumab has impacted the prospect of treating the condition.